Terms ending in 2037
Every in-force patent on Amgen Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,419,933 | Pharmaceutical Composition Comprising Bispecific Antibody Constructs In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,822,408 | Pacap Antibodies and Uses Thereof In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,857,229 | Treatment of Ovarian Cancer in Patients with Ascites Using a Specific Binding Agent of Human ANGIOPOIETIN-2 in Combination with a Taxane In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,872,282 | Treatment of Ovarian Cancer in Patients with Ascites Using a Specific Binding Agent of Human ANGIOPOIETIN-2 in Combination with a Taxane In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,301,391 | Bcma and CD3 Bispecific T Cell Engaging Antibody Constructs In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,781,264 | PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs In force · High confidence | Amgen Research (Munich) GmbH | In force | High confidence | |
| US 11,434,302 | Bispecific T Cell Engaging Antibody Constructs In force · High confidence | Amgen Research (Munich) GmbH | In force | High confidence | |
| US 12,799,224 | Bispecific T Cell Engaging Antibody Constructs In force · High confidence | Amgen Research (Munich) GmbH | In force | High confidence | |
| US 10,088,660 | Imaging System for Counting and Sizing Particles in Fluid-Filled Vessels In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,539,773 | Imaging System for Counting and Sizing Particles in Fluid-Filled Vessels In force · Medium confidence | Amgen Inc. | In force | Medium confidence | |
| 71 more term ends in 2037 · Pro | |||||
10 of 81 patents shown. Soonest term end first, then patent number.
Pro members see all 81.
79 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.